Read + Share
Wu HL, Luo ZY, He ZL, Gong Y, et al. Correction to: All HER2-negative breast cancer patients need gBRCA testing:
cost-effectiveness and clinical benefits. Br J Cancer 2023 Jan 30. doi: 10.1038/s41416-023-02159.
PMID: 36717677
|
 |
|
Wu HL, Luo ZY, He ZL, Gong Y, et al. Correction to: All HER2-negative breast cancer patients need gBRCA testing:
cost-effectiveness and clinical benefits. Br J Cancer 2023 Jan 30. doi: 10.1038/s41416-023-02159.
PMID: 36717677
|
|
|
|